DiNicolantonio J, OKeefe J
Open Heart. 2022; 9(1).
PMID: 35236761
PMC: 8896029.
DOI: 10.1136/openhrt-2022-001989.
Isaacks R, BENDER A, Kim C, Prieto N, Norenberg M
Neurochem Res. 1994; 19(3):331-8.
PMID: 8177373
DOI: 10.1007/BF00971582.
Wachtel R, Kraske S, Yorek M
J Membr Biol. 1995; 145(2):187-92.
PMID: 7563020
DOI: 10.1007/BF00237376.
Gillon K, HAWTHORNE J
Biochem J. 1983; 210(3):775-81.
PMID: 6870806
PMC: 1154289.
DOI: 10.1042/bj2100775.
Mayhew J, Gillon K, HAWTHORNE J
Diabetologia. 1983; 24(1):13-5.
PMID: 6825977
DOI: 10.1007/BF00275940.
Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect.
Greene D, Lattimer S
J Clin Invest. 1982; 70(5):1009-18.
PMID: 6813354
PMC: 370313.
DOI: 10.1172/jci110688.
Free inositol, sorbitol and fructose levels in sciatic nerve.
Sherman W, Dyck P
Diabetologia. 1983; 25(5):452-3.
PMID: 6653946
DOI: 10.1007/BF00282530.
Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon K, HAWTHORNE J, Tomlinson D
Diabetologia. 1983; 25(4):365-71.
PMID: 6416913
DOI: 10.1007/BF00253203.
Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.
Greene D, Lattimer S
J Clin Invest. 1983; 72(3):1058-63.
PMID: 6309904
PMC: 1129273.
DOI: 10.1172/JCI111030.
Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
MAYER J, Tomlinson D
Diabetologia. 1983; 25(5):433-8.
PMID: 6197336
DOI: 10.1007/BF00282524.
Retrograde axonal transport. A possible role in the development of neuropathy.
Sidenius P, Jakobsen J
Diabetologia. 1981; 20(2):110-2.
PMID: 6162698
DOI: 10.1007/BF00262011.
Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients.
Hale P, Nattrass M, Silverman S, Sennit C, Perkins C, Uden A
Diabetologia. 1987; 30(7):464-7.
PMID: 3666344
DOI: 10.1007/BF00279613.
Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting P, ROSS I
Br J Exp Pathol. 1988; 69(5):697-702.
PMID: 3143396
PMC: 2013281.
Reduced Na+ + K+-ATPase activity in peripheral nerve of streptozotocin-diabetic rats: a role for protein kinase C?.
Simpson C, HAWTHORNE J
Diabetologia. 1988; 31(5):297-303.
PMID: 2840314
DOI: 10.1007/BF00277411.
Renal structure and function in streptozotocin-diabetic rats treated with cyclosporin A.
Thomson K, Saunders N, Simpson J, Whiting P
Br J Exp Pathol. 1989; 70(4):405-14.
PMID: 2765393
PMC: 2040564.
A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes.
Zhu X, EICHBERG J
Proc Natl Acad Sci U S A. 1990; 87(24):9818-22.
PMID: 2263632
PMC: 55265.
DOI: 10.1073/pnas.87.24.9818.
Correction of abnormal small intestinal cytosolic protein kinase C activity in streptozotocin-induced diabetes by insulin therapy.
Wali R, Dudeja P, Bolt M, Sitrin M, Brasitus T
Biochem J. 1990; 272(3):653-8.
PMID: 2176470
PMC: 1149758.
DOI: 10.1042/bj2720653.
Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain.
Leong S, Leung T
Neurochem Res. 1991; 16(10):1161-5.
PMID: 1665546
DOI: 10.1007/BF00966596.
